Profile data is unavailable for this security.
About the company
Cambium Bio Limited, formerly Regeneus Ltd, is an Australia-based clinical-stage regenerative medicine company focusing on the development of biologics for ophthalmology and tissue repair applications. Its technology, based on human platelet lysate, is being leveraged to create a pipeline of novel therapeutics, with a primary focus on ophthalmology. Its lead product candidate, Elate Ocular, is being developed to address significant unmet medical needs in the treatment of dry eye disease. Elate Ocular is formulated from the processing of base human platelets sourced not from patients, but generally healthier younger eligible donors at U.S. blood collection centers. In addition, its stem cell platform, Progenza, is being applied to the development of therapies for knee osteoarthritis and other tissue repair indications. It also manufactures and sells stem cell growth supplements, such as UltraGRO Advanced, UltraGRO Pure (xeno-free), and UltraGRO Pure GI (xeno-free, gamma irradiated).
- Revenue in AUD (TTM)128.99k
- Net income in AUD-2.26m
- Incorporated2007
- Employees--
- LocationCambium Bio Ltd2 Paddington Street, PaddingtonPYMBLE 2021AustraliaAUS
- Phone+61 29499-8010
- Fax+61 29499-8020
- Websitehttps://regeneus.com.au/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BPH Global Ltd | 109.97k | -1.60m | 991.60k | 31.00 | -- | -- | -- | 9.02 | -0.0052 | -0.0076 | 0.0004 | -0.0122 | 0.1017 | 3.72 | 1.57 | -- | -164.32 | -68.84 | -- | -147.67 | 16.61 | 16.85 | -1,616.43 | -146.38 | 0.1796 | -84.22 | -- | -- | 32,244.12 | -41.18 | 62.50 | -- | -- | -- |
Wellfully Ltd | 1.31m | -1.34m | 1.48m | 36.00 | -- | -- | -- | 1.13 | -0.003 | -0.003 | 0.0034 | -0.0034 | 0.377 | 0.3166 | 1.57 | -- | -38.36 | -175.88 | -- | -441.84 | 48.61 | -- | -101.74 | -266.08 | 0.2159 | -- | -- | -- | -42.78 | -5.87 | 12.98 | -- | 21.75 | -- |
Hexima Ltd | 61.67k | -933.87k | 2.84m | -- | -- | 0.1406 | -- | 46.05 | -0.0559 | -0.0559 | 0.0037 | 0.121 | 0.0236 | -- | 0.1523 | -- | -35.74 | -74.86 | -38.89 | -189.88 | -- | -- | -1,514.30 | -274.35 | -- | -- | 0.00 | -- | -95.85 | -55.24 | 51.33 | -- | -- | -- |
Vectus Biosystems Ltd | 76.86k | -2.34m | 4.26m | -- | -- | 2.86 | -- | 55.38 | -0.044 | -0.044 | 0.0014 | 0.0279 | 0.0231 | -- | 0.0638 | -- | -70.26 | -84.62 | -88.42 | -227.56 | -- | -- | -3,042.06 | -12,407.49 | 3.45 | -389.35 | 0.00 | -- | 38.46 | 222.59 | 32.07 | -- | -- | -- |
Cambium Bio Ltd | 128.99k | -2.26m | 4.65m | -- | -- | 1.68 | -- | 36.07 | -0.4599 | -0.4599 | 0.0173 | 0.2327 | 0.0318 | -- | 1.00 | -- | -55.60 | -30.97 | -144.62 | -99.20 | 62.39 | -- | -1,748.79 | -74.07 | -- | -149.70 | 0.1443 | -- | -- | -- | -33.72 | -- | -- | -- |
Neuroscientific Biopharmaceuticals Ltd | 2.39m | 324.21k | 5.21m | -- | 15.86 | 0.973 | 12.53 | 2.18 | 0.0023 | 0.0023 | 0.0165 | 0.037 | 0.4458 | -- | 48.82 | -- | 6.04 | -46.72 | 6.46 | -51.16 | -- | -- | 13.56 | -199.33 | -- | 33.42 | 0.00 | -- | -52.76 | 82.13 | 130.34 | -- | -37.50 | -- |
Invex Therapeutics Ltd | 1.70m | -1.64m | 6.24m | -- | -- | 1.10 | -- | 3.66 | -0.0218 | -0.0218 | 0.0227 | 0.0757 | 0.1178 | -- | 7.95 | -- | -11.35 | -15.73 | -12.20 | -16.55 | -- | -- | -96.35 | -535.37 | -- | -- | 0.00 | -- | 35.66 | 566.05 | 78.81 | -- | -- | -- |
Avecho Biotechnology Ltd | 339.30k | -3.48m | 6.34m | 29.00 | -- | 1.50 | -- | 18.68 | -0.0012 | -0.0012 | 0.0001 | 0.0013 | 0.0693 | 4.26 | 0.7043 | -- | -71.20 | -47.08 | -105.46 | -55.25 | -45.60 | 78.67 | -1,026.91 | -156.43 | 3.48 | -- | 0.0316 | -- | -58.07 | -19.42 | -46.71 | -- | -- | -- |
Holista Colltech Limited | 5.46m | -4.64m | 6.41m | 3.00 | -- | -- | -- | 1.17 | -0.0166 | -0.0166 | 0.0196 | -0.0094 | 1.48 | 3.54 | 5.39 | -- | -125.43 | -42.59 | -1,528.79 | -63.58 | 51.69 | 56.37 | -85.04 | -39.27 | 0.2094 | -282.55 | -- | -- | -27.82 | -5.65 | -230.77 | -- | -37.12 | -- |
Patrys Ltd | 1.39m | -3.54m | 7.20m | 15.00 | -- | 2.07 | -- | 5.17 | -0.0017 | -0.0017 | 0.0007 | 0.0017 | 0.2386 | -- | 0.6665 | -- | -60.57 | -52.81 | -68.65 | -56.79 | -- | -- | -253.86 | -249.64 | -- | -- | 0.00 | -- | -51.11 | 10.55 | 49.88 | -- | -4.41 | -- |
Zelira Therapeutics Ltd | 1.02m | -36.57m | 8.34m | 8.00 | -- | -- | -- | 8.14 | -3.22 | -3.22 | 0.0902 | -0.3979 | 0.0524 | 0.0609 | 5.06 | -- | -188.05 | -46.98 | -246.20 | -50.16 | 91.73 | -- | -3,587.90 | -1,063.82 | 0.424 | -6.78 | 3.35 | -- | -82.72 | -35.59 | -556.18 | -- | -- | -- |